Ankita Ray

Ankita Ray

Auto-generated profile, based on publicly available information

Ankita Ray

Louvain Institute of Biomolecular Science and Technology, Université Catholique de Louvain

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 September 2021 in Nature Reviews Methods Primers
Verified
Journal Article
Closed access
PDF file
Albertus ViljoenAlbertus Viljoen
Albertus Viljoen
Marion Mathelié-GuinletMarion Mathelié-Guinlet
Marion Mathelié-Guinlet
ARAnkita Ray
Ankita Ray
NSNico Strohmeyer
Nico Strohmeyer
YOYoo Jin Oh
Yoo Jin Oh
YDYves Dufrene
Yves Dufrene

30 November 2021 in Nature Communications
Verified
Journal Article
Open access
PDF file
MKMelanie Koehler
Melanie Koehler
ARAnkita Ray
Ankita Ray
RSRodrigo Azevedo Moreira da Silva
Rodrigo Azevedo Moreira da Silva
BJBlinera Juniku
Blinera Juniku
Adolfo B. PomaAdolfo B. Poma
Adolfo B. Poma
DADavid Alsteens
David Alsteens
Despite an unprecedented global gain in knowledge since the emergence of SARS-CoV-2, almost all mechanistic knowledge related to the molecular and cellular details of viral replication, pathology and virulence has been generated using early prototypic isolates of SARS-CoV-2. Here, using atomic force microscopy and molecular dynamics, we investigated how these mutations quantitatively affected the kinetic, thermodynamic and structural properties of RBD—ACE2 complex formation. We observed for several variants of concern a significant increase in the RBD—ACE2 complex stability. While the N501Y and E484Q mutations are particularly important for the greater stability, the N501Y mutation is unlikely to significantly affect antibody neutralization. This work provides unprecedented atomistic detail on the binding of SARS-CoV-2 variants and provides insight into the impact of viral mutations on infection-induced immunity.

7 October 2020 in Chemical Science
Verified
Journal Article
Open access
PDF file
AFAlessandro Fracassi
Alessandro Fracassi
JCJianbo Cao
Jianbo Cao
NYNaoko Yoshizawa-Sugata
Naoko Yoshizawa-Sugata
ÉTÉva Tóth
Éva Tóth
CACorey Archer
Corey Archer
YYYoko Yamakoshi
Yoko Yamakoshi
Low-density lipoprotein (LDL)-mimetic lipid nanoparticles (LNPs), decorated with MRI contrast agents and fluorescent dyes, were prepared by the covalent attachment of apolipoprotein-mimetic peptide (P), Gd(III)-chelate (Gd), and sulforhodamine B (R) moieties on the LNP surface. The functionalized LNPs were prepared using the amide-forming potassium acyltrifluoroborate (KAT) ligation reaction. The KAT groups on the surface of LNPs were allowed to react with the corresponding hydroxylamine (HA) derivatives of P and Gd to provide bi-functionalized LNPs (PGd-LNP). The reaction proceeded with excellent yields, as observed by ICP-MS (for B and Gd amounts) and MALDI-TOF-MS data, and did not alter the morphology of the LNPs (mean diameter: ca. 50 nm), as shown by DLS and cryoTEM analyses. With the help of the efficient KAT ligation, a high payload of Gd(III)-chelate on the PGd-LNP surface (ca. 2800 Gd atoms per LNP) was successfully achieved and provided a high r1 relaxivity (r1 = 22.0 s−1 mM−1 at 1.4 T/60 MHz and 25 °C; r1 = 8.2 s−1 mM−1 at 9.4 T/400 MHz and 37 °C). This bi-functionalized PGd-LNP was administered to three atherosclerotic apoE−/− mice to reveal the clear enhancement of atherosclerotic plaques in the brachiocephalic artery (BA) by MRI, in good agreement with the high accumulation of Gd in the aortic arch as shown by ICP-MS. The parallel in vivo MRI and ex vivo studies of whole mouse cryo-imaging were performed using triply functionalized LNPs with P, Gd, and R (PGdR-LNP). The clear presence of atherosclerotic plaques in BA was observed by ex vivo bright field cryo-imaging, and they were also observed by high emission fluorescent imaging. These directly corresponded to the enhanced tissue in the in vivo MRI of the identical mouse.

9 February 2023 in Nano Letters
Verified
Journal Article
Open access
JSJoshua Simpson
Joshua Simpson
ARAnkita Ray
Ankita Ray
CMClaire Marcon
Claire Marcon
RNRita dos Santos Natividade
Rita dos Santos Natividade
GDGol Mohammad Dorrazehi
Gol Mohammad Dorrazehi
DADavid Alsteens
David Alsteens
Despite intense scrutiny throughout the pandemic, development of efficacious drugs against SARS-CoV-2 spread remains hindered. Understanding the underlying mechanisms of viral infection is fundamental for developing novel treatments. While angiotensin converting enzyme 2 (ACE2) is accepted as the key entry receptor of the virus, other infection mechanisms exist. Dendritic cell-specific intercellular adhesion molecule-3 grabbing non-integrin (DC-SIGN) and its counterpart DC-SIGN-related (DC-SIGNR, also known as L-SIGN) have been recognized as possessing functional roles in COVID-19 disease and binding to SARS-CoV-2 has been demonstrated previously with ensemble and qualitative techniques. Here we examine the thermodynamic and kinetic parameters of the ligand-receptor interaction between these C-type lectins and the SARS-CoV-2 S1 protein using force-distance curve-based AFM and biolayer interferometry. We evidence that the S1 receptor binding domain is likely involved in this bond formation. Further, we employed deglycosidases and examined a nonglycosylated S1 variant to confirm the significance of glycosylation in this interaction. We demonstrate that the high affinity interactions observed occur through a mechanism distinct from that of ACE2.

24 August 2020 in The Journal of Physical Chemistry Letters
Verified
Journal Article
Closed access
ARAnkita Ray
Ankita Ray
KLKorinne Liosi
Korinne Liosi
SRShivaprakash N. Ramakrishna
Shivaprakash N. Ramakrishna
NSNicholas Spencer
Nicholas Spencer
Akinori KuzuyaAkinori Kuzuya
Akinori Kuzuya
YYYoko Yamakoshi
Yoko Yamakoshi

9 May 2024 in Cell Host & Microbe
Verified
Journal Article
Closed access
PSPengcheng Shang
Pengcheng Shang
RNRita dos Santos Natividade
Rita dos Santos Natividade
GTGwen M. Taylor
Gwen M. Taylor
ARAnkita Ray
Ankita Ray
OWOlivia L. Welsh
Olivia L. Welsh
TDTerence S. Dermody
Terence S. Dermody